Cargando…
Drug formulation augments the therapeutic response of carboplatin administered through a lymphatic drug delivery system
Treatment of metastatic lymph nodes (LNs) is challenging due to their unique architecture and biophysical traits. Systemic chemotherapy fails to impede tumor progression in LNs due to poor drug uptake and retention by LNs, resulting in fatal systemic metastasis. To effectively treat LN metastasis, a...
Autores principales: | Mishra, Radhika, Sukhbaatar, Ariunbuyan, Dorai, Arunkumar, Mori, Shiro, Shiga, Kiyoto, Kodama, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807524/ https://www.ncbi.nlm.nih.gov/pubmed/36168838 http://dx.doi.org/10.1111/cas.15599 |
Ejemplares similares
-
Intranodal pressure of a metastatic lymph node reflects the response to lymphatic drug delivery system
por: Kato, Shigeki, et al.
Publicado: (2020) -
Study of the physicochemical properties of drugs suitable for administration using a lymphatic drug delivery system
por: Fukumura, Ryoichi, et al.
Publicado: (2021) -
Treatment of false‐negative metastatic lymph nodes by a lymphatic drug delivery system with 5‐fluorouracil
por: Fujii, Honoka, et al.
Publicado: (2019) -
Combination therapy of lymphatic drug delivery and total body irradiation in a metastatic lymph node and lung mouse model
por: Sora, Shota, et al.
Publicado: (2022) -
Metastatic lymph node targeted CTLA4 blockade: a potent intervention for local and distant metastases with minimal ICI-induced pneumonia
por: Mishra, Radhika, et al.
Publicado: (2023)